These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings. J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S1-S83. PubMed ID: 2480479 [No Abstract] [Full Text] [Related]
4. [Enoximone in the treatment of acute heart failure. Paris, 9-10 March 1990. Proceedings]. Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():11-117. PubMed ID: 2147828 [No Abstract] [Full Text] [Related]
5. [Enoximone in the treatment of acute cardiac insufficiency]. Brochier M. Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():11. PubMed ID: 2147827 [No Abstract] [Full Text] [Related]
17. Enoximone. A review of its pharmacological properties and therapeutic potential. Vernon MW, Heel RC, Brogden RN. Drugs; 1991 Dec 14; 42(6):997-1017. PubMed ID: 1724645 [Abstract] [Full Text] [Related]
18. Long-term enoximone therapy in unstable chronic heart failure. Treese N, Rhein S, Erbel R, Meyer J. J Cardiovasc Pharmacol; 1989 Dec 14; 14 Suppl 1():S78-83. PubMed ID: 2480491 [Abstract] [Full Text] [Related]
19. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone]. Holubarsch C, Hasenfuss G, Thierfelder L, Heiss HW, Just H. Z Kardiol; 1991 Dec 14; 80 Suppl 4():35-40. PubMed ID: 1833895 [Abstract] [Full Text] [Related]